Price $165.47 |
Market Cap
33.62B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
56.9
|
P/B
2.88
|
P/S
5.53
|
Dividend %
-
|
|
P/CF
109.4
|
P/FCF
11.7
|
Op. Cash Flow
3M
|
FCF
13.0
|
|
Op. Margin
10.40%
|
Net Margin
9.90%
|
ROE
5.40%
|
ROI
4.30%
|
|
ROA
3.40%
|
EPS Growth
-74.40%
|
Current Ratio
3.6
|
Debt/Equity
21.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| NuVasive, Inc. (NUVA) | $68.75 | - | - | 3.37B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.28 | - | - | 12.5B | Strong Buy |
| Medicure Inc (MCUJF) | $1.32 | - | - | 12.6M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $65.60 | - | 3.10% | 141.03B | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.99 | - | - | 45.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
